Melhores Quimioterapia médicos em Israel - TOP-32 médicos

O Dr. Pelles Sharon é especialista em técnicas avançadas de quimioterapia, incluindo Quimioterapia Intraperitoneal Hipertérmica (HIPEC) no Centro Médico Sourasky.

• Especialista em imunoterapia e terapia direcionada para vários tipos de câncer
• Conduziu pesquisa clínica sobre as atitudes dos pacientes em relação aos ensaios
• Realiza procedimentos complexos como a cirurgia de Whipple e ressecções hepáticas
• Oferece múltiplas abordagens de quimioterapia adaptadas ao tipo de câncer

Especialista líder em sarcoma e oncologia ortopédica com extensa experiência clínica e de pesquisa no Sourasky Medical Center.

• Chefe da Unidade de Oncologia Óssea e de Tecidos Moles desde 2000
• Treinamento de fellowship concluído no Institut Gustave Roussy, Paris
• Membro do corpo docente do grupo Sarcoma da ESMO
• Trabalho pioneiro em pesquisa de imunologia tumoral
• Ex-presidente da Sociedade Israelense de Oncologia e Radioterapia

O Dr. Sarid é um oncologista experiente no Centro Médico Sourasky, com mais de 15 anos de especialização em quimioterapia e terapia biológica do câncer.

• Oncologista Sênior no Centro Médico Sourasky desde 2009
• Investigador principal de ensaios clínicos em terapias contra o câncer
• Autor de mais de 30 artigos sobre o tratamento do câncer
• Membro da Sociedade Europeia de Oncologia Médica e da Sociedade Americana de Oncologia Clínica
• Formado na Universidade de Oxford com especialidade em urologia oncológica

Especialista em Ginecologia Oncológica e Radioterapia – Tamar Sapra traz experiência focada para o tratamento de quimioterapia no Sourasky Medical Center (Ichilov).

• Especializa-se em casos de oncologia ginecológica
• Combina quimioterapia com radioterapia para cuidados abrangentes
• Trabalha em um dos principais centros médicos de Israel

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

O Dr. Ari Raphael lidera pesquisas inovadoras em câncer de pulmão e de mama no Sourasky Medical Center, com foco em medicina genômica e imunoterapia.

• Investigador principal em ensaios clínicos sobre pembrolizumabe e imunoterapia neoadjuvante
• Especialista em perfil genômico abrangente e biópsias líquidas
• Modera o Conselho de Tumores Moleculares da Sociedade Israelense de Câncer de Pulmão
• Professor de destaque na Faculdade de Medicina da Universidade de Tel-Aviv

Chefe da Divisão de Oncologia Médica no Centro Médico Sourasky – o Dr. Wolf é especializado em tratamentos avançados de quimioterapia.

• Vasta experiência em oncologia e medicina interna
• Formação pela Universidade Ben Gurion do Neguev
• Serviço anterior em Unidades Médicas do Exército
• Fluente em inglês para pacientes internacionais

O Dr. Michael Shapira é especialista em Transplante de Medula Óssea, com mais de 20 anos de experiência desde a sua graduação na Faculdade de Medicina da Universidade Hebraica.

• Médico sênior no departamento de Transplante de Medula Óssea do Hadassah Medical Center
• Treinamento em medicina interna realizado no Hadassah Medical Center
• Fluente em inglês e hebraico para uma comunicação confortável com o paciente

A Dra. Dvora Blumental liderou serviços de neuro-oncologia em instituições de ponta, como o Huntsman Cancer Institute e o Sourasky Medical Center.

• Especialista em neuro-oncologia com mais de 25 anos de experiência
• Treinamento realizado no Memorial Sloan-Kettering Cancer Center
• Diretora do Serviço de Neuro-oncologia no Instituto de Oncologia
• Especialista no tratamento de cânceres cerebrais e do sistema nervoso

O Dr. Fredi Aviv possui 31 anos de experiência especializada em onco-hematologia no Sourasky Medical Center.

• Especializa-se em quimioterapia para cânceres relacionados ao sangue
• Pratica em um dos principais centros médicos de Israel
• Certificado pelo Conselho (Board-certified) em onco-hematologia

Diretor de Internamento Oncológico no Centro Médico de Tel Aviv – Dr. Stepfansky lidera uma equipe de oncologia dedicada em Ichilov.

• Mais de 15 anos de experiência em oncologia
• Especializou-se em medicina interna antes de se concentrar em oncologia
• Investigador principal em ensaios clínicos de fase I a III
• Treinamento no prestigioso programa de oncologia do Centro Médico de Tel Aviv

O Dr. Dror Levin é especializado em hemato-oncologia pediátrica, com foco no câncer ósseo (sarcoma) em crianças. Ele lidera o departamento de hemato-oncologia infantil no Sourasky Medical Center em Tel Aviv.

• Pediatra sênior no Hospital Infantil 'Dana'
• Especialização em hematologia e oncologia pediátricas no Centro Médico Infantil Schneider
• Treinamento em oncologia óssea e de tecidos moles no Instituto Ortopédico Rizzoli na Itália
• Membro da associação israelense de hemato-oncologia pediátrica (ISPHO)

O Dr. Sonnenblick é especializado em tratamentos para câncer de mama, incluindo quimioterapia, radioterapia e terapias-alvo, como o Keytruda. Ele apresentou trabalhos em mais de 30 reuniões científicas nacionais e internacionais.

• Ganhador de múltiplos prêmios, incluindo o ESMO Breast Cancer Translational Research Award
• Membro de sociedades oncológicas de prestígio, como a ESMO e a EACR
• Realizou uma bolsa de aperfeiçoamento (fellowship) em pesquisa de câncer de mama na Emory University e no Instituto Jules Bordet

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.